Discover the latest insights in the "Respiratory Syncytial Virus (RSV) Infections - Global Clinical Trials Review, 2025." This comprehensive report details RSV clinical trial data, including trial ...

RSV vaccines are 82% effective for older people and 72% for newborns when mothers are vaccinated at least 14 days before ...

In older adults, respiratory syncytial virus (RSV) is associated with an increased risk for cardiovascular outcome, especially heart failure events.

Nirsevimab is effective for protecting infants against respiratory syncytial virus (RSV)-associated lower respiratory tract ...

Dr. R.W. Mills, Chief Medical Officer for Nationwide Children's Hospital - Toledo, talks about what to know about RSV as kids ...

Beyond COVID-19, there are several vaccines seniors should prioritize for optimal health. These include protection against ...

Samples taken from the Erie Wastewater Treatment Plant are now being tested for measles, opioid drugs and nicotine.

A heartbroken mum is urging SA families to take the flu seriously after her partner with a pre-existing condition died ...

The investigators noted cardiovascular events for up to 1 year post-discharge in 18.5% of RSV patients, compared with 17.7% ...

SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the ...

The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find ...